減量および肥満管理の世界市場:産業分析・市場機会

【英語タイトル】Weight Loss and Obesity Management Market: Global Industry Analysis 2013-2017 and Opportunity Assessment 2018-2028

Future Market Insightsが出版した調査資料(FUMI906198)・商品コード:FUMI906198
・発行会社(調査会社):Future Market Insights
・発行日:2019年2月
・ページ数:276
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:医療・製薬
◆販売価格オプション(消費税別)
Individual Price(1名様閲覧用)USD5,000 ⇒換算¥545,000見積依頼/購入/質問フォーム
Corporate Price(同一法人内共有可)USD7,500 ⇒換算¥817,500見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
※本調査レポートでは、減量および肥満管理の世界市場について調査・分析し、以下の構成でお届けいたします。
・減量および肥満管理の世界市場の世界市場概観
・減量および肥満管理の世界市場の世界市場規模
・減量および肥満管理の世界市場の世界市場予測
・減量および肥満管理の世界市場の世界市場:地域別市場分析
・減量および肥満管理の世界市場のアメリカ市場規模
・減量および肥満管理の世界市場のヨーロッパ市場規模
・減量および肥満管理の世界市場のアジア市場規模
・減量および肥満管理の世界市場の世界市場:製品別(装置、薬)
・減量および肥満管理の世界市場の世界市場:競争状況
・減量および肥満管理の世界市場の世界市場:市場動向
・減量および肥満管理の世界市場の世界市場:関連企業分析
【レポートの概要】

A recent market study published by the company – “Weight Loss and Obesity Management: Global Industry Analysis 2013 – 2017 and Forecast 2018 – 2028,” consists of a comprehensive assessment of the most important market dynamics. By conducting a thorough research on the historical as well as current growth parameters of the weight loss and obesity management market, the growth prospects of the market are obtained with maximum precision.

The report features unique and salient factors that may have a huge impact on the development of the weight loss and obesity management market during the forecast period. It can help the players to modify their manufacturing and marketing strategies to envisage maximum growth in the weight loss and obesity management in the upcoming years. The report provides detailed information about the current and future growth prospects of the weight loss and obesity management market in the most comprehensive way for better understanding of the readers.

Chapter 1 – Executive Summary

The report commences with the executive summary of the weight loss and obesity management market, which includes the summary of key findings and statistics of the market. It also includes the market value (US$ million) estimates of the leading segments of the weight loss and obesity management market.

Chapter 2 – Market Overview

Readers can find detailed taxonomy and the definition of the weight loss and obesity management market in this chapter, which helps understand the basic information about the weight loss and obesity management. This section also highlights the inclusions and exclusions, which helps the reader understand the scope of the weight loss and obesity management market report.

Chapter 3 – Key Success Factors

This chapter highlights the key success factors of the weight loss and obesity management market report, which include regulatory scenario for medical devices and drugs, pipeline assessment of drugs for obesity, potential of anti-obesity drugs in the market, entry strategies, white space analysis, and list of key manufacturers. The key regulations section of this chapter highlights the FDA and EMA regulatory processes for the approval of drugs and devices.

Chapter 4 – Global Weight Loss and Obesity Management Market – Pricing Analysis

This section highlights the average price of laser assisted liposuction devices, radio frequency assisted liposuction devices, ultrasound assisted liposuction devices, bariatric stapling devices, gastric band, gastric balloon systems, gastric emptying systems, and gastric electrical stimulation systems in the different region throughout the globe. The pricing benchmark for manufacturer level pricing and distributor level pricing is analysed in this section.

Chapter 5 – Global Weight Loss and Obesity Management Market Demand (in Value or Size in US$ Mn) Analysis 2013-2017 and Forecast, 2018-2028

This section explain the global market value analysis and forecast for the weight loss and obesity management market between the forecast periods of 2013-2028 is highlights in this section.

Chapter 6 – Market Background

This chapter explains the key macro-economic factors that are expected to influence the growth of the weight loss and obesity management market over the forecast period. Along with macroeconomic factors, this section also highlights the opportunity analysis for the weight loss and obesity management market. This chapter also highlights the key market dynamics of the weight loss and obesity management market, which include the drivers, restraints and trends. Moreover, readers will understand the key trends followed by the leading manufacturers in the weight loss and obesity management market.

Chapter 7 – Global Weight Loss and Obesity Management Market Analysis 2013-2017 and Forecast 2018-2028, By Product Type

Based on the product type, the weight loss and obesity management market is segmented into drugs and devices. The drugs segment is further segmented into GLP-1 receptor agonists, lipase inhibitors, serotonin receptor agonist, combination drug, and others. The devices segment is further segmented into liposuction devices, bariatric stapling devices, gastric band, gastric balloon systems, gastric emptying systems, and gastric electrical stimulation systems. In this chapter, readers can find information about the key trends and developments in the weight loss and obesity management market and market attractive analysis based on the type of products.

Chapter 8 – Global Weight Loss and Obesity Management Market Analysis 2013-2017 and Forecast 2018-2028, By Distribution Sales

Based on the distribution sales, the weight loss and obesity management market is segmented into institutional sales and retail sales. Intuitional sales is further segmented into Hospitals, Weightloss Clinics, and Ambulatory Surgery Centers. Retail sales is segmented into retail pharmacies, drug stores, and online sales. In this chapter, the readers can find information about the key trends and developments in the weight loss and obesity management market and market attractive analysis based on distribution sales.

Chapter 9 – Global Weight Loss and Obesity Management Market Analysis 2013-2017 and Forecast 2018-2028, By Region

This chapter explains how the weight loss and obesity management market will grow across various geographic regions, such as North America, Latin America, Europe, South Asia, East Asia, Oceania, Middle East & Africa (MEA), and emerging countries.

Chapter 10 – North America Weight Loss and Obesity Management Market Analysis 2013-2017 and Forecast 2018-2028

This chapter includes a detailed analysis of the growth of the North America weight loss and obesity management market along with a country-wise assessment including the U.S. and Canada. Readers can also find market growth based on product type, distribution sales, and country for the weight loss and obesity management market in North America.

Chapter 11 – Latin America Weight Loss and Obesity Management Market Analysis 2013-2017 and Forecast 2018-2028

This chapter contains a snapshot of the Latin America weight loss and obesity management market. It includes the growth prospects of the weight loss and obesity management market in the leading LATAM countries such as Brazil, Mexico, and the rest of the Latin America region.

Chapter 12 – Europe Weight Loss and Obesity Management Market Analysis 2013-2017 and Forecast 2018-2028

The important growth prospects of the weight loss and obesity management market based on its product type, and distribution sales in several European countries, such as the U.K., Germany, France, Italy Spain, Russia and the rest of Europe, is included in this chapter.

Chapter 13 – South Asia Weight Loss and Obesity Management Market Analysis 2013-2017 and Forecast 2018-2028

India, Indonesia, Thailand , Malaysia are the leading countries in the South Asia region that are the prime subjects of assessment to obtain the growth prospects of the South Asia weight loss and obesity management market in this chapter. Readers can find detailed information about the growth parameters of the South Asia weight loss and obesity management market during the period 2018-2028.

Chapter 14 – East Asia Weight Loss and Obesity Management Market Analysis 2013-2017 and Forecast 2018-2028

This chapter highlights the growth of the weight loss and obesity management market in the East Asia by focusing on China, Japan and South Korea. This section also helps readers understand the key factors that are responsible for the growth of the weight loss and obesity management market in East Asia.

Chapter 15 – Oceania Weight Loss and Obesity Management Market Analysis 2013-2017 and Forecast 2018-2028

Readers can find important factors that can significantly impact the growth of the weight loss and obesity management market in Australia and New Zealand during the forecast period based on the market segmentation.

Chapter 16 – Middle East and Africa Weight Loss and Obesity Management Market Analysis 2013-2017 and Forecast 2018-2028

This chapter provides information about the growth of the weight loss and obesity management market in the major countries of the MEA region, such as GCC Countries, Turkey and South Africa, during the period 2018-2028.

Chapter 17 – Emerging Countries Weight Loss and Obesity Management Market Analysis 2013-2017 and Forecast 2018-2028

Readers can find important factors that can significantly impact the growth of the weight loss and obesity management market in emerging countries like China, India, and Brazil during the forecast period based on the market segmentation.

Chapter 18 – Competition Landscape

In this chapter, readers can find a comprehensive list of all the leading manufacturers in the weight loss and obesity management market, along with detailed information about each company, which includes the company overview, revenue shares, strategic overview, and recent company developments. Some of the players featured in the weight loss and obesity management market report are Novo Nordisk A/S, GlaxoSmithKline plc., F. Hoffmann-La Roche AG, Allergan Plc, Johnson & Johnson Services, Inc, Medtronic plc., Vivus Inc., Eisai Co., Ltd., ReShape Lifesciences, Inc, Obalon Therapeutics, Aspire Bariatrics, Allurion Technologies Inc., Nalpropion Pharmaceuticals, Inc., Beijing Noble Laser Technology Co., Ltd, and others.

Chapter 19 – Assumptions and Acronyms

This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the report.

Chapter 20 – Assumptions and Acronyms

This chapter helps readers understand the research methodology followed to obtain various conclusions and important qualitative information & quantitative information about the weight loss and obesity management market.

【レポートの目次】

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand Side Trends

1.3. Supply Side Trends

1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

3. Key Success Factors

3.1. Regulatory Scenario

3.2. Pipeline Assessment

3.3. Potential of Anti-Obesity Drugs In The Market

3.4. Key Market Entry Strategies

3.5. White Space Analysis

4. Global Weight Loss and Obesity Management Market – Pricing Analysis

4.1. Regional Pricing Analysis By Product Type

4.2. Pricing Break-up

4.2.1. Manufacturer Level Pricing

4.2.2. Distributor Level Pricing

4.3. Global Average Pricing Analysis Benchmark

5. Global Weight Loss and Obesity Management Market Demand (in Value or Size in US$ Mn) Analysis 2013-2017 and Forecast, 2018-2028

5.1. Historical Market Value (US$ Mn) Analysis, 2013-2017

5.2. Current and Future Market Value (US$ Mn) Projections, 2018-2028

5.2.1. Y-o-Y Growth Trend Analysis

5.2.2. Absolute $ Opportunity Analysis

6. Market Background

6.1. Macro-Economic Factors

6.1.1. Increasing Investments Towards Obesity Treatment

6.1.2. Global Increase In Healthcare Spending

6.1.3. Shift Towards A Value-Based Healthcare Model

6.2. Forecast Factors – Relevance & Impact

6.2.1. New/Approved Product Launches

6.2.2. Treatment Rate

6.2.3. Prevalence of Obesity

6.2.4. Technological Advancements

6.2.5. Acceptance of Drugs by Prescribers

6.2.6. Reimbursement Policies

6.2.7. Product Penetration Rate Across End Users

6.2.8. Adoption Rate among Patients

6.2.9. Product Penetration across Regions

6.2.10. Penetration of Product in Different Distribution Channel

6.3. Value Chain

6.4. Market Dynamics

6.4.1. Drivers

6.4.2. Restraints

6.4.3. Opportunity Analysis

7. Global Weight Loss and Obesity Management Market Analysis 2013-2017 and Forecast 2018-2028, by Product Type

7.1. Introduction / Key Findings

7.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2013 – 2017

7.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Product Type, 2018 – 2028

7.3.1. Devices

7.3.1.1. Liposuction Device

7.3.1.1.1. Laser Assisted Liposuction Devices

7.3.1.1.2. Radio Frequency Assisted Liposuction Devices

7.3.1.1.3. Ultrasound Assisted Liposuction Devices

7.3.1.2. Bariatric Stapling Devices

7.3.1.3. Gastric Band

7.3.1.4. Gastric Balloon Systems

7.3.1.5. Gastric Emptying Systems

7.3.1.6. Gastric Electrical Stimulation Systems

7.3.2. Drugs

7.3.2.1. GLP-1 receptor agonists

7.3.2.2. Lipase Inhibitors

7.3.2.3. Serotonin Receptor Agonist

7.3.2.4. Combination Drug

7.3.2.5. Others

7.4. Market Attractiveness Analysis By Product Type

8. Global Weight Loss and Obesity Management Market Analysis 2013-2017 and Forecast 2018-2028, by Distribution Sales

8.1. Introduction / Key Findings

8.2. Historical Market Size (US$ Mn) Analysis By Distribution Sales, 2013 – 2017

8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Sales, 2018 – 2028

8.3.1. Institutional Sales

8.3.1.1. Hospitals

8.3.1.2. Weightloss Clinics

8.3.1.3. Ambulatory Surgery Centers

8.3.2. Retail Sales

8.3.2.1. Retail Pharmacies

8.3.2.2. Drug Stores

8.3.2.3. Online Sales

8.4. Market Attractiveness Analysis By Distribution Sales

9. Global Weight Loss and Obesity Management Market Analysis 2013-2017 and Forecast 2018-2028, by Region

9.1. Introduction

9.2. Historical Market Size (US$ Mn) Analysis By Region, 2013 – 2017

9.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2018 – 2028

9.3.1. North America

9.3.2. Latin America

9.3.3. Europe

9.3.4. Middle East and Africa (MEA)

9.3.5. East Asia

9.3.6. South Asia

9.3.7. Oceania

9.4. Market Attractiveness Analysis By Region

10. North America Weight Loss and Obesity Management Market Analysis 2013-2017 and Forecast 2018-2028

10.1. Introduction

10.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2013 – 2017

10.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2018 – 2028

10.3.1. By Country

10.3.1.1. U.S.

10.3.1.2. Canada

10.3.2. By Product Type

10.3.3. By Distribution Sales

10.4. Market Attractiveness Analysis

10.4.1. By Country

10.4.2. By Product Type

10.4.3. By Distribution Sales

10.5. Drivers and Restraints – Impact Analysis

11. Latin America Weight Loss and Obesity Management Market Analysis 2013-2017 and Forecast 2018-2028

11.1. Introduction

11.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2013 – 2017

11.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2018 – 2028

11.3.1. By Country

11.3.1.1. Brazil

11.3.1.2. Mexico

11.3.1.3. Rest of Latin America

11.3.2. By Product Type

11.3.3. By Distribution Sales

11.4. Market Attractiveness Analysis

11.4.1. By Country

11.4.2. By Product Type

11.4.3. By Distribution Sales

11.5. Drivers and Restraints – Impact Analysis

12. Europe Weight Loss and Obesity Management Market Analysis 2013-2017 and Forecast 2018-2028

12.1. Introduction

12.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2013 – 2017

12.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2018 – 2028

12.3.1. By Country

12.3.1.1. Germany

12.3.1.2. Italy

12.3.1.3. France

12.3.1.4. U.K.

12.3.1.5. Spain

12.3.1.6. Russia

12.3.1.7. Rest of Europe

12.3.2. By Product Type

12.3.3. By Distribution Sales

12.4. Market Attractiveness Analysis

12.4.1. By Country

12.4.2. By Product Type

12.4.3. By Distribution Sales

12.5. Drivers and Restraints – Impact Analysis

13. South Asia Weight Loss and Obesity Management Market Analysis 2013-2017 and Forecast 2018-2028

13.1. Introduction

13.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2013 – 2017

13.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2018 – 2028

13.3.1. By Country

13.3.1.1. India

13.3.1.2. Thailand

13.3.1.3. Indonesia

13.3.1.4. Malaysia

13.3.1.5. Rest of South Asia

13.3.2. By Product Type

13.3.3. By Distribution Sales

13.4. Market Attractiveness Analysis

13.4.1. By Country

13.4.2. By Product Type

13.4.3. By Distribution Sales

13.5. Drivers and Restraints – Impact Analysis

14. East Asia Weight Loss and Obesity Management Market Analysis 2013-2017 and Forecast 2018-2028

14.1. Introduction

14.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2013 – 2017

14.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2018 – 2028

14.3.1. By Country

14.3.1.1. China

14.3.1.2. Japan

14.3.1.3. South Korea

14.3.2. By Product Type

14.3.3. By Distribution Sales

14.4. Market Attractiveness Analysis

14.4.1. By Country

14.4.2. By Product Type

14.4.3. By Distribution Sales

14.5. Drivers and Restraints – Impact Analysis

15. Oceania Weight Loss and Obesity Management Market Analysis 2013-2017 and Forecast 2018-2028

15.1. Introduction

15.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2013 – 2017

15.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2018 – 2028

15.3.1. By Country

15.3.1.1. Australia

15.3.1.2. New Zealand

15.3.2. By Product Type

15.3.3. By Distribution Sales

15.4. Market Attractiveness Analysis

15.4.1. By Country

15.4.2. By Product Type

15.4.3. By Distribution Sales

15.5. Drivers and Restraints – Impact Analysis

16. Middle East and Africa Weight Loss and Obesity Management Market Analysis 2013-2017 and Forecast 2018-2028

16.1. Introduction

16.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2013 – 2017

16.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2018 – 2028

16.3.1. By Country

16.3.1.1. GCC Countries

16.3.1.2. Turkey

16.3.1.3. South Africa

16.3.1.4. Rest of Middle East and Africa

16.3.2. By Product Type

16.3.3. By Distribution Sales

16.4. Market Attractiveness Analysis

16.4.1. By Country

16.4.2. By Product Type

16.4.3. By Distribution Sales

16.5. Drivers and Restraints – Impact Analysis

17. Emerging Countries Weight Loss and Obesity Management Market Analysis 2013-2017 and Forecast 2018-2028

17.1. Introduction

17.1.1. Market Value Proportion Analysis, By Key Countries

17.1.2. Global Vs. Country Growth Comparison

17.2. China Weight Loss and Obesity Management Market Analysis

17.2.1. Introduction

17.2.2. Market Value Proportion Analysis by Market Taxonomy

17.2.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy

17.2.3.1. By Product Type

17.2.3.2. By Distribution Sales

17.2.4. China Weight Loss and Obesity Management Market – Competition Landscape

17.3. India Weight Loss and Obesity Management Market Analysis

17.3.1. Introduction

17.3.2. Market Value Proportion Analysis by Market Taxonomy

17.3.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy

17.3.3.1. By Product Type

17.3.3.2. By Distribution Sales

17.3.4. India Weight Loss and Obesity Management Market – Competition Landscape

17.4. Brazil Weight Loss and Obesity Management Market Analysis

17.4.1. Introduction

17.4.2. Market Value Proportion Analysis by Market Taxonomy

17.4.3. Market and Value (US$ Mn) Analysis and Forecast by Market Taxonomy

17.4.3.1. By Product Type

17.4.3.2. By Distribution Sales

17.4.4. Mexico Weight Loss and Obesity Management Market – Competition Landscape

18. Market Structure Analysis

18.1. Brand Share Analysis of Top Players

19. Competition Analysis

19.1. Competition Dashboard

19.2. Competition Benchmarking

19.3. Competition Deep Dive

19.3.1. Novo Nordisk A/S

19.3.1.1. Overview

19.3.1.2. Product Portfolio

19.3.1.3. Profitability by Market Segments (Product/Channel/Region)

19.3.1.4. Sales Footprint

19.3.1.5. Strategy Overview

19.3.1.5.1. Marketing Strategy

19.3.1.5.2. Product Strategy

19.3.1.5.3. Channel Strategy

19.3.2. GlaxoSmithKline plc.

19.3.3. F. Hoffmann-La Roche AG

19.3.4. Allergan Plc

19.3.5. Johnson & Johnson Services, Inc

19.3.6. Medtronic plc.

19.3.7. Vivus Inc.

19.3.8. Eisai Co., Ltd.

19.3.9. ReShape Lifesciences, Inc.

19.3.10. Obalon Therapeutics

19.3.11. Aspire Bariatrics

19.3.12. Allurion Technologies Inc.

19.3.13. Nalpropion Pharmaceuticals, Inc.

19.3.14. Cheplapharm Arzneimittel GmbH

19.3.15. Beijing Noble Laser Technology Co., Ltd

20. Assumptions and Acronyms Used

21. Research Methodology



★調査レポート[減量および肥満管理の世界市場:産業分析・市場機会] (コード:FUMI906198)販売に関する免責事項を必ずご確認ください。
★調査レポート[減量および肥満管理の世界市場:産業分析・市場機会]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆